AUROPHARMA — Aurobindo Pharma Share News
0.000.00%
Last trade - 00:00- IN₹904.32bn
- IN₹877.78bn
- IN₹336.53bn
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11
Brief: Aurobindo Pharma Says U.S. FDA Inspection At Unit-Iv Of Apitoria Pharma Private Completed
Brief: Aurobindo Pharma's Unit Launches Generic Advair Diskus In US
India's Aurobindo Pharma hits record high after unit launches generic version of Advair Diskus in US
Brief: Aurobindo Pharma Says US FDA Conducted Inspection At Lannett Company Llc From 17Th To 21St August 2026
Brief: Aurobindo Pharma Says US FDA Conducted Inspection At Auropeptides From August 17 To August 21
Brief: Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated
India Stocks: India shares inch higher at the open on Middle East peace prospects, earnings
India Stocks: India shares seen higher on Mideast peace prospects, earnings
India's Aurobindo Pharma posts quarterly profit rise on anti-retroviral drug demand
Brief: Aurobindo Pharma Q1 Consol Net PAT 10.33 Billion Rupees
India's pharma stocks fall after Trump outlines steep tariffs on generic drug imports
India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
Brief: Aurobindo Pharma USA Receives FTC Approval To Acquire Lannett Company
Brief: Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett (updated)